BROOKE GILLETT
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- Lebanon, MO
- NPI
- 1356538003
- Received
- $4,424 in 152 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 64 | $2,329 |
| 2024 | General payment | 35 | $852 |
| 2023 | General payment | 14 | $275 |
| 2022 | General payment | 9 | $237 |
| 2021 | General payment | 8 | $223 |
| 2020 | General payment | 5 | $103 |
| 2019 | General payment | 17 | $402 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 143 | $3,267 |
| Consulting Fee | 1 | $768 |
| Education | 8 | $388 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Dendreon Pharmaceuticals LLC | $30 | Food and Beverage | In-kind items and services | PROVENGE Drug, CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | 2025 | |
| 2025-12-17 | AstraZeneca Pharmaceuticals LP | $26 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-12-17 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-12-17 | E.R. Squibb & Sons, L.L.C. | $1 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-12-10 | Karyopharm Therapeutics Inc. | $18 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-12-05 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-12-03 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-12-02 | PFIZER INC. | $30 | Education | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-12-02 | PFIZER INC. | $30 | Education | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-12-02 | PFIZER INC. | $30 | Education | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-12-01 | E.R. Squibb & Sons, L.L.C. | $6 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-11-19 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-11-13 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-11-11 | Bayer Healthcare Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-11-05 | Eisai Inc. | $18 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-11-04 | Janssen Biotech, Inc. | $77 | Education | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-11-03 | SERVIER PHARMACEUTICALS LLC | $19 | Food and Beverage | In-kind items and services | Tibsovo Drug, Oncology | 2025 | |
| 2025-10-30 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-10-23 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-10-22 | Exelixis Inc. | $26 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-10-15 | BeOne Medicines USA, Inc. | $25 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-10-15 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-10-13 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-10-09 | Stemline Therapeutics Inc. | $92 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2025 | |
| 2025-10-08 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-09-22 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2025 | |
| 2025-08-19 | Janssen Biotech, Inc. | $121 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-08-13 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-07-30 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-07-30 | ARRAY BIOPHARMA INC | $6 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2025 | |
| 2025-07-16 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-07-02 | Incyte Corporation | $17 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-06-18 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-06-05 | JAZZ PHARMACEUTICALS INC. | $20 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-06-04 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-29 | BeOne Medicines USA, Inc. | $31 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-05-21 | Daiichi Sankyo Inc. | $26 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-05-15 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-05-08 | Exelixis Inc. | $18 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-05-07 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-05-07 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-05-07 | E.R. Squibb & Sons, L.L.C. | $1 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-05-06 | Sumitomo Pharma America, Inc. | $19 | Food and Beverage | In-kind items and services | ORGOVYX Drug, PROSTATE CANCER | 2025 | |
| 2025-04-30 | Stemline Therapeutics Inc. | $30 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2025 | |
| 2025-04-25 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-04-23 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-04-21 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-04-11 | TAIHO ONCOLOGY, INC. | $21 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-03-31 | GENZYME CORPORATION | $13 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-03-28 | BeOne Medicines USA, Inc. | $21 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-03-27 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-03-26 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-03-13 | AstraZeneca Pharmaceuticals LP | $121 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-03-12 | ARRAY BIOPHARMA INC | $15 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-03-05 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-03-05 | AstraZeneca Pharmaceuticals LP | $2 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-03-04 | Stemline Therapeutics Inc. | $23 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2025 | |
| 2025-02-26 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-02-18 | Dendreon Pharmaceuticals LLC | $27 | Food and Beverage | In-kind items and services | PROVENGE Drug, CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | 2025 | |
| 2025-02-13 | ARRAY BIOPHARMA INC | $23 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-02-12 | Daiichi Sankyo Inc. | $768 | Consulting Fee | Cash or cash equivalent | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-01-29 | Eisai Inc. | $16 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-01-16 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-01-16 | E.R. Squibb & Sons, L.L.C. | $11 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2024-12-18 | Genentech USA, Inc. | $14 | Food and Beverage | In-kind items and services | Columvi Biological, BioOncology | 2024 | |
| 2024-12-12 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-11-21 | GENZYME CORPORATION | $22 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-11-20 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-11-15 | Daiichi Sankyo Inc. | $27 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-11-12 | Pharmacosmos Therapeutics Inc. | $23 | Food and Beverage | In-kind items and services | COSELA Drug, HEMATOLOGY | 2024 | |
| 2024-11-11 | Celgene Corporation | $24 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2024 | |
| 2024-10-23 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-10-21 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2024 | |
| 2024-10-07 | Gilead Sciences, Inc. | $18 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2024 | |
| 2024-09-25 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2024 | |
| 2024-09-17 | Genentech USA, Inc. | $17 | Food and Beverage | In-kind items and services | Tecentriq Biological, BioOncology | 2024 | |
| 2024-09-11 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-09-09 | Stemline Therapeutics Inc. | $16 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2024 | |
| 2024-08-19 | Celgene Corporation | $20 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-08-14 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2024 | |
| 2024-07-31 | AstraZeneca Pharmaceuticals LP | $126 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-31 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-07-23 | Regeneron Healthcare Solutions, Inc. | $19 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2024 | |
| 2024-07-09 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | LUTATHERA Drug, Oncology | 2024 | |
| 2024-07-08 | JAZZ PHARMACEUTICALS INC. | $21 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-07-03 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-06-28 | SANOFI-AVENTIS U.S. LLC | $93 | Education | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-06-24 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-06-10 | GENZYME CORPORATION | $16 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-06-05 | Eisai Inc. | $21 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2024 | |
| 2024-05-22 | Genentech USA, Inc. | $24 | Food and Beverage | In-kind items and services | Alecensa Biological, BioOncology | 2024 | |
| 2024-05-09 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2024 | |
| 2024-04-25 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2024 | |
| 2024-04-24 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-03-28 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2024 | |
| 2024-03-26 | GENZYME CORPORATION | $17 | Food and Beverage | In-kind items and services | ALPROLIX Biological, Hematology | 2024 | |
| 2024-03-18 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-03-13 | Merck Sharp & Dohme LLC | $15 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-02-29 | Eisai Inc. | $13 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2024 | |
| 2023-11-16 | Celgene Corporation | $19 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2023 | |
| 2023-11-15 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2023 | |
| 2023-11-14 | Janssen Biotech, Inc. | $22 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2023 | |
| 2023-11-06 | Novartis Pharmaceuticals Corporation | $14 | Food and Beverage | In-kind items and services | PIQRAY Drug, Oncology | 2023 | |
| 2023-10-30 | GENZYME CORPORATION | $13 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2023 | |
| 2023-10-23 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | PROMACTA Drug, Oncology | 2023 | |
| 2023-10-09 | PharmaEssentia USA Corporation | $22 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2023 | |
| 2023-10-07 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2023 | |
| 2023-08-01 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2023 | |
| 2023-06-12 | PUMA BIOTECHNOLOGY, INC. | $20 | Food and Beverage | In-kind items and services | NERLYNX Drug, ONCOLOGY | 2023 | |
| 2023-05-05 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2023 | |
| 2023-04-25 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2023 | |
| 2023-03-31 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2023 | |
| 2023-02-14 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2023 | |
| 2022-12-06 | SOBI, INC | $17 | Food and Beverage | In-kind items and services | DOPTELET Drug, HEMATOLOGY/ONCOLOGY | 2022 | |
| 2022-11-08 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2022 | |
| 2022-10-18 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2022 | |
| 2022-10-12 | SOBI, INC | $13 | Food and Beverage | In-kind items and services | DOPTELET Drug, HEMATOLOGY/ONCOLOGY | 2022 | |
| 2022-08-22 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2022 | |
| 2022-08-04 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2022 | |
| 2022-07-27 | Janssen Biotech, Inc. | $99 | Education | In-kind items and services | DARZALEX Biological, Oncology | 2022 | |
| 2022-03-25 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2022 | |
| 2022-03-22 | Acrotech Biopharma Inc. | $13 | Education | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2022 | |
| 2021-11-09 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2021 | |
| 2021-09-28 | Epizyme, Inc. | $91 | Food and Beverage | In-kind items and services | TAZVERIK Drug, ONCOLOGY | 2021 | |
| 2021-09-22 | Daiichi Sankyo Inc. | $19 | Food and Beverage | In-kind items and services | INJECTAFER Drug, Iron Deficiency Anemia | 2021 | |
| 2021-06-14 | Daiichi Sankyo Inc. | $14 | Food and Beverage | In-kind items and services | INJECTAFER Drug, Iron Deficiency Anemia | 2021 | |
| 2021-06-01 | Gilead Sciences, Inc. | $11 | Education | In-kind items and services | 2021 | ||
| 2021-05-14 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2021 | |
| 2021-03-16 | Lilly USA, LLC | $20 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2021 | |
| 2021-03-01 | Medtronic, Inc. | $38 | Food and Beverage | In-kind items and services | KYPHON Balloon Kyphoplasty Device, Neuro Pain (includes Interventional) | 2021 | |
| 2020-05-12 | Amgen Inc. | $11 | Food and Beverage | In-kind items and services | Vectibix Biological, Oncology | 2020 | |
| 2020-02-13 | Takeda Pharmaceuticals U.S.A., Inc. | $14 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-02-04 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2020 | |
| 2020-01-24 | PFIZER INC. | $28 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2020 | |
| 2020-01-07 | PFIZER INC. | $29 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2020 | |
| 2019-11-18 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | KANJINTI Biological, Oncology | 2019 | |
| 2019-11-15 | Pharmacyclics LLC, an AbbVie Company | $11 | Food and Beverage | In-kind items and services | Imbruvica Drug, Oncology | 2019 | |
| 2019-11-13 | Bayer Healthcare Pharmaceuticals Inc. | $10 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2019 | |
| 2019-11-02 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | ALIMTA Drug, Oncology | 2019 | |
| 2019-10-29 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-10-11 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-10-11 | PFIZER INC. | $2 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-10-10 | PFIZER INC. | $28 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-10-10 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-08-28 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-08-28 | PFIZER INC. | $4 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-08-23 | PFIZER INC. | $29 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-08-23 | PFIZER INC. | $4 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-07-24 | Cardinal Health 110 LLC | $68 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-03-15 | Foundation Medicine, Inc. | $25 | Food and Beverage | In-kind items and services | FOUNDATIONONE Device, ONCOLOGY | 2019 | |
| 2019-02-25 | Lilly USA, LLC | $23 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2019 | |
| 2019-02-20 | PORTOLA PHARMACEUTICALS, LLC | $98 | Food and Beverage | In-kind items and services | ANDEXXA Biological, HEMATOLOGY/NEUROLOGY | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Lebanon, MO, county Laclede County, MO, state Missouri; placed by its city name.
| Measure | Place (city or town) Lebanon, MO | County Laclede County, MO | State Missouri |
|---|---|---|---|
| Population B01003 | 15,270 | 36,390 | 6,191,814 |
| Population, 2020 census P1 | 15,013 | 36,039 | 6,154,913 |
| Median age B01002 | 37.4 | 39.2 | 39.0 |
| Under 18 B01001 | 25.7% | 24.6% | 22.3% |
| 65 and over B01001 | 16.9% | 18.3% | 17.9% |
| Households B11001 | 6,338 | 14,558 | 2,508,227 |
| Foreign born B05002 | 2.1% | 1.5% | 4.5% |
| Median household income B19013 | $48,359 | $53,282 | $70,702 |
| Median family income B19113 | $56,182 | $62,166 | $91,360 |
| Per capita income B19301 | $28,196 | $29,076 | $39,695 |
| Poverty rate B17001 | 21.7% | 18.2% | 12.6% |
| Unemployment rate B23025 | 6.9% | 5.3% | 4.0% |
| Civilian labor force B23025 | 7,371 | 17,141 | 3,120,639 |
| Mean commute (minutes) B08013 | 17.4 | 21.4 | 23.5 |
| Bachelor's degree or higher B15003 | 18.2% | 16.3% | 32.4% |
| Housing units B25001 | 7,061 | 16,012 | 2,825,287 |
| Owner-occupied B25003 | 52.1% | 68.2% | 68.1% |
| Renters B25003 | 47.9% | 31.8% | 31.9% |
| Median home value B25077 | $158,800 | $168,400 | $230,300 |
| Median gross rent B25064 | $809 | $809 | $1,033 |
| White, not Hispanic B03002 | 91.0% | 90.4% | 76.3% |
| Black B03002 | 0.5% | 0.6% | 10.9% |
| Hispanic or Latino B03002 | 4.1% | 3.0% | 5.2% |
| Asian B03002 | 1.5% | 0.8% | 2.1% |
| American Indian and Alaska Native B03002 | 0.5% | 0.3% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Lebanon, MO.
Comments